Skip to main content

Breast Cancer Research and Treatment

Ausgabe 1/2018

Inhalt (22 Artikel)

Open Access Review

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Jame Abraham, Humberto Caldera, Robert Coleman, Anthony Elias, Matthew P. Goetz, Muaiad Kittaneh, Elyse Lower, Reshma Mahtani, E. Terry Mamounas, Mark Pegram, Hope Rugo, Lee Schwartzberg, Tiffany Traina, Chuck Vogel

Open Access Review

Is invasion a necessary step for metastases in breast cancer?

Steven A. Narod, Victoria Sopik

Preclinical study

GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer

Yun-Bi Ni, Julia Y. S. Tsang, Mu-Min Shao, Siu-Ki Chan, Sai-Yin Cheung, Joanna Tong, Ka-Fai To, Gary M. Tse

Open Access Preclinical study

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement

Timco Koopman, Henk J. Buikema, Harry Hollema, Geertruida H. de Bock, Bert van der Vegt

Preclinical study

Impact of an embedded genetic counselor on breast cancer treatment

Holly J. Pederson, Najaah Hussain, Ryan Noss, Courtney Yanda, Colin O’Rourke, Charis Eng, Stephen R. Grobmyer

Preclinical study

The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ

Virginie Ory, William B. Kietzman, Jacob Boeckelman, Bhaskar V. Kallakury, Anton Wellstein, Priscilla A. Furth, Anna T. Riegel

Preclinical study

Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients

Zhenhua Fan, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie

Clinical trial

Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer

Jie Cheng, Tim Holland-Letz, Markus Wallwiener, Harald Surowy, Katarina Cuk, Sarah Schott, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Barbara Burwinkel

Clinical trial

Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis

Elisa García Garre, Ginés Luengo Gil, Silvia Montoro García, Enrique Gonzalez Billalabeitia, Marta Zafra Poves, Elena García Martinez, Vanessa Roldán Schilling, Esther Navarro Manzano, Alejandra Ivars Rubio, Gregory Y. H. Lip, Francisco Ayala de la Peña

Open Access Clinical trial

Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial

Sara Mijwel, Malin Backman, Kate A. Bolam, Emil Olofsson, Jessica Norrbom, Jonas Bergh, Carl Johan Sundberg, Yvonne Wengström, Helene Rundqvist

Epidemiology

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

Florentia Fostira, Emmanouil Saloustros, Paraskevi Apostolou, Andromahi Vagena, Despoina Kalfakakou, Davide Mauri, Dimitrios Tryfonopoulos, Vassileios Georgoulias, Drakoulis Yannoukakos, Georgios Fountzilas, Irene Konstantopoulou

Epidemiology

Associations of coffee consumption and caffeine intake with mammographic breast density

Lusine Yaghjyan, Graham Colditz, Bernard Rosner, Aleksandra Gasparova, Rulla M. Tamimi

Epidemiology

Assessment of potential risk factors for breast cancer in a population in Southern Brazil

Juliana Zeni Breyer, Eliana Marcia Wendland, Natália Luiza Kops, Maira Caleffi, Luciano Serpa Hammes

Epidemiology

Living with chronic pain: perceptions of breast cancer survivors

Ting Bao, Andrew Seidman, Qing Li, Christina Seluzicki, Victoria Blinder, Salimah H. Meghani, John T. Farrar, Jun J. Mao

Epidemiology

Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry

Tarsha Jones, Debra Duquette, Meghan Underhill, Chang Ming, Kari E. Mendelsohn-Victor, Beth Anderson, Kara J. Milliron, Glenn Copeland, Nancy K. Janz, Laurel L. Northouse, Sonia M. Duffy, Sofia D. Merajver, Maria C. Katapodi

Epidemiology

Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence

Charlotte Pourcelot, Emeline Orillard, Gilles Nallet, Camille Dirand, François Billion-Rey, Garance Barbier, Sarah Chouk, Samuel Limat, Philippe Montcuquet, Julie Henriques, Sophie Paget-Bailly, Amélie Anota, Loïc Chaigneau, Virginie Nerich

Epidemiology

Trajectories of quality of life following breast cancer diagnosis

Neha G. Goyal, Beverly J. Levine, Kimberly J. Van Zee, Elizabeth Naftalis, Nancy E. Avis

Epidemiology

Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative

Lu Zhang, Qingzhao Yu, Xiao-Cheng Wu, Mei-Chin Hsieh, Michelle Loch, Vivien W. Chen, Elizabeth Fontham, Tekeda Ferguson

Brief Report

Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience

Krishan R. Jethwa, Mohamed M. Kahila, Kristin C. Mara, William S. Harmsen, David M. Routman, Geralyn M. Pumper, Kimberly S. Corbin, Jeff A. Sloan, Kathryn J. Ruddy, Tina J. Hieken, Sean S. Park, Robert W. Mutter

Brief Report

Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience

Nafisha Lalani, Karen M. Winkfield, Daniel E. Soto, Beow Y. Yeap, Andrea K. Ng, Peter M. Mauch, Rachel B. Jimenez

Rebuttal Letter

Reply to K. Altundag

E. A. Underwood, M. C. Tierney

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.